Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: Gabapentin for Bipolar & Cannabis Use Disorders [Phase 2]
Phase 2 clinical trial investigating gabapentin for bipolar disorder and cannabis use disorders has completed with results posted.
-
FDA approval · 2020-11-09FDA Approved: OLANZAPINE — Supplemental Application (Dr. Reddy's Laboratories Ltd.)
FDA approved a supplemental application for olanzapine from Dr. Reddy's Laboratories, establishing a generic version of the drug. The action…
-
FDA approval · 2020-11-09FDA Approved: OLANZAPINE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
The FDA approved a supplemental application for olanzapine filed by Dr. Reddy's Laboratories Inc., indicating regulatory approval related to…
-
CLINICAL_TRIALS trial_result · 2020-11-09Clinical Trial Update: Effectiveness of a Mobile Texting Intervention for People With Serious Mental Illness [NA]
Clinical trial update on a mobile texting intervention for people with serious mental illness has completed with posted results.
-
FDA approval · 2020-10-30FDA Approved: PALIPERIDONE — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for paliperidone (generic) submitted by NorthStar RxLLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-10-30FDA Approved: QUETIAPINE EXTENDED RELEASE — Supplemental Application (ACI Healthcare USA, Inc.)
FDA approves a supplemental application for a generic quetiapine extended-release product by ACI Healthcare USA, Inc.
-
FDA approval · 2020-10-30FDA Approved: VALPROIC ACID — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Valproic Acid submitted by ANI Pharmaceuticals, Inc.
-
FDA approval · 2020-10-29FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Geodon (ziprasidone) submitted by Viatris Specialty LLC.
-
FDA approval · 2020-10-28FDA Approved: RISPERIDONE — Supplemental Application (Natco Pharma USA LLC)
The FDA approved a supplemental application for Risperidone from Natco Pharma USA LLC under an ANDA.
-
FDA approval · 2020-10-26FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries Inc)
FDA approved a generic version of chlorpromazine hydrochloride under Original Application for Sun Pharmaceutical Industries Inc, expanding a…
-
EMA withdrawal · 2020-10-22EMA Application withdrawn: Abilify MyCite (aripiprazole) — Otsuka Pharmaceutical Netherlands B.V.
The EMA has withdrawn the application for Abilify MyCite (aripiprazole) by Otsuka Pharmaceutical Netherlands B.V.
-
FDA approval · 2020-10-22FDA Approved: OLANZAPINE — Original Application (Eugia US LLC)
FDA approved the Original Application for olanzapine submitted by Eugia US LLC. The approval covers a generic olanzapine product indicated f…
-
CLINICAL_TRIALS trial_result · 2020-10-20Clinical Trial Update: Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders [Phase 3]
Phase 3 placebo-controlled trial of valproate and risperidone in young children with bipolar disorder completed; results posted.
-
FDA approval · 2020-10-19FDA Approved: RISPERIDONE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for risperidone by Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Prevention of Relapse & Recurrence of Bipolar Depression [Phase 4]
Phase 4 clinical trial evaluating prevention of relapse and recurrence in bipolar depression has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Cost- Effectiveness and Quality of Life Assessment in Bipolar Disorder Depressive Episode [Phase 4]
A Phase 4 cost-effectiveness and quality-of-life assessment study in bipolar disorder depressive episode has completed with results posted.
-
FDA approval · 2020-10-09FDA Approved: LAMICTAL — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Lamictal (lamotrigine) from GlaxoSmithKline LLC. The action typically involves changes to la…
-
FDA approval · 2020-10-09FDA Approved: LAMICTAL — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Lamictal (lamotrigine) filed by GlaxoSmithKline, leading to changes in the product labeling.
-
FDA approval · 2020-10-09FDA Approved: LAMICTAL ODT — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Lamictal ODT (lamotrigine) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2020-10-09FDA Approved: LAMICTAL XR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Lamictal XR (lamotrigine) submitted by GlaxoSmithKline LLC. The action relates to Lamictal XR un…
-
CLINICAL_TRIALS trial_result · 2020-10-06Clinical Trial Update: 18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolar Disorder [Phase 4]
Phase 4 trial updating the use of 18F-DOPA PET to understand how lurasidone may exert antidepressant effects in bipolar depression; results …
-
FDA approval · 2020-09-11FDA Approved: LITHIUM CARBONATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for lithium carbonate from Glenmark Pharmaceuticals, approving a supplemental filing related to …
-
FDA approval · 2020-09-09FDA Approved: LITHIUM CARBONATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for lithium carbonate from Glenmark Pharmaceuticals Inc., USA, regarding the approved product.
-
CLINICAL_TRIALS trial_result · 2020-09-07Clinical Trial Update: Study of Maca Root to Treat Sexual Dysfunction Associated With the Treatment Regimen for Bipolar Disorder in Females [Phase 3]
Phase 3 trial evaluating maca root for sexual dysfunction associated with bipolar disorder treatment in females was terminated; results post…
-
CLINICAL_TRIALS trial_result · 2020-09-02Clinical Trial Update: Cost- Effectiveness and Quality of Life Assessment in Mood Disorder [Phase 4]
Phase 4 trial update assessing cost-effectiveness and quality of life in bipolar disorder; results posted.